ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Envarsus XR Use Can Benefit Serum Creatinine Levels in Vascularized Composite Allotransplantation Patients

C. M. Cooney1, V. Javia1, J. Littleton1, D. S. Cooney1, R. J. Redett1, J. T. Shores1, D. C. Brennan2, G. Brandacher1

1Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 2Surgery, Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: 2020 American Transplant Congress

Abstract number: D-242

Keywords: FK506, Immunosuppression, Renal function

Session Information

Session Name: Poster Session D: VCA

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Vascularized composite allotransplantation (VCA) is a life-enhancing (as opposed to life-saving) procedure. Therefore, minimizing adverse outcomes associated with chronic immunosuppression is vital to determining VCA’s risk/benefit ratio. We use an immunosuppression minimization protocol in which tacrolimus is the single drug; however, tacrolimus has a well-known potential for nephrotoxicity. Here we present data on 5 patients whom we switched from tacrolimus immediate-release (PROGRAF) to tacrolimus extended-release (ENVARSUS XR) with the intention of preserving these patients’ kidney health.

*Methods: We performed a retrospective review of serum creatinine levels from 4 hand (Patients 1-4) and 1 penis transplant (Patient 5) recipient, whom we switched from tacrolimus immediate-release (PROGRAF) to tacrolimus extended-release (ENVARSUS XR) with the intention of preserving these patients’ kidney health. Serum creatinine levels were assessed starting 3-months post-transplant or when the patient first came under our care.

*Results: Patients were transitioned to ENVARSUS XR at 7.5 (Patient 1), 5.5 (Patient 2), 2.9 (Patient 3), 0.25 (Patient 4), and 0.8 (Patient 5) years post-transplant. Patient 1 continued to demonstrate a rise in serum creatinine and progressive renal failure. Patients 2, 3, and 5 demonstrated less between-test serum creatinine variability than when on PROGRAF. Patient 4 was transitioned to ENVARSUS XR 3 months post-transplant and has no stabile pre-ENVARSUS XR data to compare; however, this patient showed similarly stabile between-test serum creatinine levels.

*Conclusions: Transitioning patients to extended release immunosuppression can stabilize serum creatinine levels and reduce the risk of nephrotoxicity with the potential added benefit of improved medication compliance. This is important for any transplant and particularly for those whose primary goal is improved quality of life.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Cooney CM, Javia V, Littleton J, Cooney DS, Redett RJ, Shores JT, Brennan DC, Brandacher G. Envarsus XR Use Can Benefit Serum Creatinine Levels in Vascularized Composite Allotransplantation Patients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/envarsus-xr-use-can-benefit-serum-creatinine-levels-in-vascularized-composite-allotransplantation-patients/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences